Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial.
Ka Shing CheungTao LyuZijie DengShaowei HanLi NiJuan WuJing Tong TanJian QinHo-Yu NgWai K LeungWai-Kay SetoPublished in: Helicobacter (2024)
Chinese Clinical Trial Registry (No. ChiCTR2200056375). Registered on February 4, 2022, https://www.chictr.org.cn/showproj.aspx?proj=14131.